Drug & medication recalls Moderate risk

AstraZeneca Pharmaceuticals LP recalls Tudorza Pressair (aclindinium bromide inhalation powder), 400 mcg per actuation, 60 Metered Doses per Inhaler, Rx Only.…

Recall date
February 5, 2016
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
D-0781-2016
FDA classification
Class II
Brand / firm
AstraZeneca Pharmaceuticals LP
Sold / distributed
US: Nationwide Including Puerto Rico

Why it was recalled

Defective Delivery System: Some units have actuation counters set to a number other than 60.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Tudorza Pressair (aclindinium bromide inhalation powder), 400 mcg per actuation, 60 Metered Doses per Inhaler, Rx Only. Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. Manufactured by: Forest Laboratories, Ireland Limited, Dublin 17 Ireland. Product of Spain. NDC: 0310-0800-60.

Get recall alerts

Free email alert whenever AstraZeneca Pharmaceuticals LP has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: AstraZeneca Pharmaceuticals LP